Emergence of Acquired HIV Drug Resistance Among Individuals Receiving Dolutegravir-Based Antiretroviral Therapy in Uganda: A National Laboratory-Based Survey 2023

The increase in DTG resistance among both children and adults highlights the need to strengthen adherence and enhance early identification of individuals at risk of HIVDR through novel and existing programmatic interventions.

Authors

Institutions

Publication Details

Journal
Open Forum Infectious Diseases
Published
2025-11-06
DOI
https://doi.org/10.1093/ofid/ofaf679
Citations
2
Primary Topic
HIV/AIDS drug development and treatment
Type
article
Field-Weighted Citation Impact
2.79

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Emergence of Acquired HIV Drug Resistance Among Individuals Receiving Dolutegravir-Based Antiretroviral Therapy in Uganda: A National Laboratory-Based Survey 2023

Grace Namayanja, Pontiano Kaleebu, Hudson Balidawa, Edward Mbidde et al.
2 citations
Open Forum Infectious Diseases
HIV/AIDS drug development and treatment
2.79
article

Emergence of Acquired HIV Drug Resistance Among Individuals Receiving Dolutegravir-Based Antiretroviral Therapy in Uganda: A National Laboratory-Based Survey 2023

Grace Namayanja, Pontiano Kaleebu, Hudson Balidawa, Edward Mbidde, Grace Sanyu, Eleanor Namusoke Magongo, Mina Ssali, Christine Watera, Alisen Ayitewala, Elliot Raizes, Du-Ping Zheng, Mary Naluguza, Maria Nannyonjo, Cordelia Katureebe, Jonathan Ntale, Miriam Nabukenya, Ronald Busobozi, Esther Nazziwa, Deogratius Ssemwanga, Juliet Asio, Clement Zeh, Hellen Nansumba, Stephanie Hackett, Juliana da Silva, Sherri Pals, Usher Kabuga Kaganda
article en
2 citations

Abstract

The increase in DTG resistance among both children and adults highlights the need to strengthen adherence and enhance early identification of individuals at risk of HIVDR through novel and existing programmatic interventions.

Open Forum Infectious DiseasesVol. 12(12)
Ministry of Health (UG), Centers for Disease Control and Prevention (UG), National Public Health Laboratory (NP), Central Research Laboratories (United Kingdom) (GB), Uganda Virus Research Institute (UG)
World Health Organization, U.S. President’s Emergency Plan for AIDS Relief, London School of Hygiene and Tropical Medicine, Centers for Disease Control and Prevention, Johnson Cancer Research Center, Kansas State University, Medical Research Council
Openalex Percentile: Top 8%
HIV/AIDS drug development and treatment
2.79
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.